Global High Throughput Screening (HTS) Market report offers the latest industry trends, technological alteration and forecast data. A deep-dive view of High Throughput Screening (HTS) industry based on its size, growth, development plans, and opportunities is offered by this report. The forecast information, SWOT analysis, High Throughput Screening (HTS) barriers, and feasibility study are the vital aspects evaluated in this report.
The global high throughput screening (HTS) market size is
anticipated to value at USD 30.91 billion by 2025, during the forecast period.
HTS market is subject to show a substantial growth due to the growing emphasis
on drug discovery and development coupled with increasing investment by
governmental agencies and research institutes. With recent advancement in
technology and growing need for automation for liquid handling, formation of
innovative platforms, and improvements in existing analytical tools allows to
handle large sets of data, thus driving growth of the high throughput screening
(HTS) market exponentially. Furthermore, rising competition between various
healthcare and pharmaceutical organizations to revolutionize drug discovery is
catering to the growth of the HTS market in coming years.
Get Free PDF
Sample (Including Full TOC, List of Tables & Figures) @ https://www.millioninsights.com/industry-reports/high-throughput-screening-hts-market/request-sample
Constant demand for high throughput screening (HTS) in research
and production areas is further propelling growth of the HTS market. Globally,
the high throughput screening (HTS) market is predicted to grow at CAGR of
7.89% in forecast period, providing numerous opportunities for market players
to invest for research and development in the HTS market. High throughput
screening, commonly referred as a high content screening (HCS), majorly adopted
to carry out various genetic, biochemical, and pharmacology studies to help in
the drug discovery procedure involving drug design to medicine trails and
analysis of the effects caused by drug interactions. High throughput screening
(HTS) procedure consists of high-tech software, numerous instruments to manage
liquids, and other detectors to allows rapid identification of active
materials, genetic modifications, and biochemical interactions.
Mounting demand for highly effective therapies to cure
various diseases has led to the adoption of technology in drug discovery.
Monitoring of large amount of processed data and screening are some of the
critical processes that has to be handled with high precision to achieve
required outcome. The latest trends in the drug discovery involves formation of
numerous biochemical libraries to establish set of standards and record
results, thus escalating growth of the high throughput screening (HTS) market.
Though, adoption of such procedure require specific set of skillset and
advanced software to manage and save large amount of data at high speed, lack
of which hampers growth of the high throughput screening (HTS) market.
Numerous governmental and private agencies are assigned
to monitor stringent quality checks and standards to attain required integrity
and precision for the obtained data, thus fueling growth of the HTS market over
forecast period. Yet, unavailability advanced software to control automated
instruments and liquid handling systems is significantly hampering growth of
the market. Nevertheless, one of the biggest advantage associated with the use
of the high throughput screening (HTS) is reduction of time to formulate a drug
discovery.
The market is divided into regional market segment such
as North America, Europe, Asia-Pacific, Latin America and Africa. North America
has shown major growth in recent years owing to the rise adoption of latest
methodologies in the healthcare sector for R&D purposes and existence
well-established market players in the region.
Asia-Pacific region is predicted to hold major market
share in the high throughput screening (HTS) industry with massive growth in
forecast period. Countries such as India, China and Japan are leading the
Asia-Pacific market with recent technological advancements in drug discovery
techniques with the use of 3D-cell cultures and substantial investment by
prominent industry players due to potential opportunities in the region.
The key players in the high throughput screening (HTS)
market are Agilent Technologies Incorporations, Danaher Co., Thermofisher
Scientific Incorporations, PerkinElmer Incorporations, Tecan Group Limited,
Hamilton Company, and Aurora Biomed Co.
Know More Insights
@ https://newsonmarketblog.wordpress.com
No comments:
Post a Comment